$WT

WT Maintained by Goldman Sachs -- Price Target Raised to $21.30

Goldman Sachs maintained a Neutral rating on WisdomTree (WT) but raised its price target to $21.30 from $18.30. GuruFocus values WT at $17.65, suggesting a 41% overvaluation. The company has a GF Score of 82/100, with strong profitability and growth but low valuation metrics. Insiders have sold $736,800 worth of shares in the last three months.

Original reporting
Published Oct 2, 2026, 5:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 6:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$WT
Neutral
high confidence
Mentioned
$WT
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$WTNeutralMed
01

Why it matters

The analyst upgrade provides fresh guidance but is tempered by a Neutral rating and valuation concerns, likely resulting in modest market reaction.

02

Market read

Primary analyst action on a mid‑cap financial services stock; modest trading relevance.

03

What to watch

Insider selling of $736,800 and a high P/E ratio suggest underlying concerns that may outweigh the target raise.

Relevance 7/10Novelty 6/10Timing: today

Background

WisdomTree is a $3.77 bn asset‑management firm known for ETFs and digital‑asset products. The firm currently trades at a significant premium to its intrinsic value.

Company-level read

Ticker impact

$WTNeutralHigh confidence
Context

Goldman Sachs raised its price target for WisdomTree to $21.30 and kept a Neutral rating, providing fresh analyst guidance.

Expected impact

potential modest pressure as the market weighs the higher target against current premium

Evidence & confidence

The new target is a primary disclosure from a major broker; however, the rating remains Neutral and the stock trades well above intrinsic value, suggesting limited bullish impact.

Market effects

May prompt a brief review of other asset‑management stocks as analysts reassess valuation multiples.

Limited to U.S. equity markets, primarily the financial services sector.

Low; the news is company‑specific without broader macro implications.

Counterpoint

Despite the higher target, the stock's 41% premium could lead to a pullback if investors prioritize valuation over growth potential.

Key entities

  • Goldman Sachs

    Maintained Neutral rating and raised price target for WisdomTree.

  • WisdomTree Inc.

    Asset‑management firm whose stock is the subject of the rating update.

Related articles

$WTMed

WisdomTree (WT) Stock Is Up, What You Need To Know

WisdomTree (WT) stock rose 2.9% after Goldman Sachs increased its price target to $21.30, citing improved earnings and industry outlook. Shares later settled at $24.40, up 1.5% from the previous close. WT has seen volatility, with 11 moves over 5% in the past year. The stock is up 95% YTD, near its 52-week high of $25.04.

$WTMed

WT Maintained by Craig-Hallum -- Price Target Raised to $29.00

Craig-Hallum raised its price target for WisdomTree (WT) to $29.00 from $24.00, maintaining a 'Buy' rating. The stock is currently priced at $24.73, which GuruFocus deems 40.1% overvalued. WT has a GF Score™ of 82/100, showing strong performance but concerns over valuation. Insiders have sold $736,800 in shares recently, with no purchases.

$WTMed

Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move?

WisdomTree (WT) reported record AUM of $162.9B in Q2 2026, up 30% YoY, with revenue at $177.2M and 40.5% operating margin. The company partnered with MoonPay to integrate its tokenized fund WTGXX, accessing 35M accounts. Despite GAAP losses from debt repurchases, management highlights long-term growth potential in digital assets. WT trades at a forward P/E of 17.30.

$WTMed

WisdomTree Announces Second Quarter 2026 Results

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju

$WTMed

WisdomTree (NYSE:WT) Delivers Strong Q2 CY2026 Numbers

Asset management firm WisdomTree (NYSE: WT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 57.3% year on year to $177.2 million. Its non-GAAP profit of $0.31 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy WisdomTree? Find out by accessing our full research report, it’s free. "The second quarter demonstrated the quality of WisdomTree's growth.

$WTMedAI 8/10

WisdomTree (WT) Launches Physical AI, Humanoids, Drones ETF (WDRN) Focused on Real-World Automation

WisdomTree (NYSE:WT) launched the Physical AI, Humanoids, and Drones ETF (WDRN) on May 14, targeting companies applying AI to physical tasks. The fund has a 0.45% expense ratio and focuses on humanoid robotics, autonomous drones, smart manufacturing, and logistics automation, using a rules-based, quarterly rebalanced index. The report says it aims to track the shift from digital AI to real-world automation.